Treatment of sarcopenia and glucose intolerance through mitochondrial activation by 5-aminolevulinic acid

Treatment of sarcopenia and glucose intolerance through mitochondrial activation by 5-aminolevulinic acid

Abstract Recently, sarcopenia has attracted attention as therapeutic target because it constitutes a risk factor for metabolic and cardiovascular diseases. We focused 5-aminolevulinic acid (ALA) which act as electron carriers in the mitochondrial electron transport system. The mice that received ALA...

Full description

Saved in:
Bibliographic Details
Main Authors: Chikako Fujii, Kazutoshi Miyashita, Masanori Mitsuishi, Masaaki Sato, Kentaro Fujii, Hiroyuki Inoue, Aika Hagiwara, Sho Endo, Asuka Uto, Masaki Ryuzaki, Motowo Nakajima, Tohru Tanaka, Masanori Tamaki, Ayako Muraki, Toshihide Kawai, Hiroshi Itoh
Format: article
Language:EN
Published: Nature Portfolio 2017
Subjects:
Medicine
R
Science
Q
Online Access:https://doaj.org/article/3bbd0cbf26ea4990bafd6f92fe58cde9
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items